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Redox signalingApart from complex I (NADH:ubiquinone oxidoreductase) the mitochondrial cytochrome bc1 complex (com-
plex III; ubiquinol:cytochrome c oxidoreductase) has been identiﬁed as the main producer of superoxide and
derived reactive oxygen species (ROS) within the mitochondrial respiratory chain. Mitochondrial ROS are
generally linked to oxidative stress, aging and other pathophysiological settings like in neurodegenerative
diseases. However, ROS produced at the ubiquinol oxidation center (center P, Qo site) of complex III seem
to have additional physiological functions as signaling molecules during cellular processes like the adaptation
to hypoxia. The molecular mechanism of superoxide production that is mechanistically linked to the electron
bifurcation during ubiquinol oxidation is still a matter of debate. Some insight comes from extensive kinetic
studies with mutated complexes from yeast and bacterial cytochrome bc1 complexes. This review is intended
to bridge the gap between those mechanistic studies and investigations on complex III ROS in cellular signal
transduction and highlights factors that impact superoxide generation. This article is part of a Special Issue
entitled: Respiratory complex III and related bc complexes.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are generally regarded as a major source of reactive
oxygen species (ROS) in eukaryotic cells [1]. Within mitochondria,
respiratory chain complexes I (NADH:ubiquinone oxidoreductase) and
III (cytochrome bc1 complex; ubiquinol:cytochrome c oxidoreductase)
are considered as the main producers of superoxide and derived reactive
oxygen species [2–4]. So far, an elevated ROS production of mitochondria
has been mainly associated with pathophysiological settings including
neurodegenerative diseases [5], oxidative damage during ischemia/reper-
fusion injury [6] and the aging process [7,8]. However, recentﬁndings and
novel concepts imply a role of (mitochondrial) ROS as regulatory agents
in a number of biological phenomena [9–11]. Especially complex III de-
rived ROS have been linked to cellular redox signaling pathways, e.g. hyp-
oxic stabilization of HIF-1α [12–15], but a detailed understanding of the
molecular mechanisms that trigger the generation of ‘signaling ROS’ is
missing. Insights into themolecularmechanismof superoxide production
came from studies aiming to elucidate the bioenergetic function of theeroxide; Q, ubiquinone; QH2,
uinone reduction site; Qo site/
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l rights reserved.cytochrome bc1 complex to pump protons across inner mitochondrial
and bacterial cytoplasmic membranes. The protonmotive Q-cycle ﬁrst
proposed by Peter Mitchell [16,17] is generally accepted as the funda-
mental mechanism of proton pumping [18–22]. It has been shown a
long time ago [23,24] that superoxide is formed at the ubiquinol oxidation
center (Qo site, center P) of the cytochrome bc1 complex and a
semiquinone as an intermediate of ubiquinol oxidation has been pro-
posed as the immediate electron donor for oxygen [25–27]. However, re-
cent studies [28–30] have shown that superoxide production from the Qo
site is stimulated by the presence of oxidized ubiquinone suggesting that
the electron might be transferred onto oxygen from reduced cytochrome
bL via ubiquinone in a reverse reaction rather than during the forward
Q-cycle reaction. This ﬁnding might have some implications for the
production of ‘signaling ROS’ [31]. This review summarizes the current
knowledge of superoxide production by the cytochrome bc1 complex
and also intends to build a bridge between mechanistic studies and
investigations on cellular redox signaling including factors/proteins that
inﬂuence mitochondrial ROS generation and release.
2. Mechanism of superoxide generation by complex III
2.1. Bioenergetic background: the protonmotive Q-cycle
2.1.1. A brief overview
The pioneering concept of Peter Mitchell on the molecular mecha-
nism of the H+-pumping cytochrome bc1 complex (complex III)
known as the protonmotive Q-cycle [16,17] has been approved by
numerous studies (reviewed in [18–22]), though a few reﬁnements
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supportedby the crystal structures of cytochrome bc1 complexes frombo-
vine [32,33], chicken [34], yeast [35–37] and bacteria [38–40] that deﬁne
the positions of the electron-transferring cofactors and reveal possible
proton conduction pathways and the structural organization of the two
ubiquinone binding sites. However, the exact position of the ubiqui-
none(s) at the Qo site has not been resolved yet [41,42]. Three transmem-
brane subunits of complex III that are conserved from bacteria to
mammals contain all prosthetic groups involved in the redox reactions:
the diheme cytochrome b, cytochrome c1 and the so-called Rieske protein
containing a unique [2Fe–2S] cluster inwhich one of the two iron atoms is
coordinated by two histidines rather than two cysteines. The cytochrome
bc1 complexes of the photosynthetic bacteria Rhodobacter capsulatus and
Rhodobacter sphaeroides contain only one additional subunit or none, re-
spectively and can be regarded as aminimal functional formof the proton
pump [43]. Both bacteria and the yeast Saccharomyces cerevisae [44] have
been widely used as model organisms for mutagenesis and functional
studies on the cytochrome bc1 complex. Mitochondrial complex III of
higher eukaryotes contains up to 8 additional accessory subunits that
are not essential for catalysis.
The spatial arrangement of the redox centers is the basis for vectorial
H+-transport [41,42]. The two ubiquinone-reaction centers are
located on opposite sides of the membranes and are mainly formed
by cytochrome b. The ubiquinol-oxidation center (called center P
or Qo site) resides on the positive side of the membrane and the
ubiquinone-reduction center (center N or Qi site) faces the negative
side of the membrane (Fig. 1). Furthermore, the structures demon-
strated an obligate homodimeric organization of the cytochrome
bc1 complexes [41]. The dimeric organization has functional implica-
tion as shown by extensive kinetic and mutational investigations
with bacterial and yeast complex III that indicate electron equilibra-
tion between the cytochrome b subunits [45–49] and conformational
communication between center P and center N [50,51]. It has been
proposed that such a ‘bus bar’ organization [48] would allow fast
electron exchange between all four b-hemes and diminish leak of
electrons and generation of superoxide [48,52–54]. However, it is
still controversially discussed whether both monomers operate
independently or function cooperatively [55,56]. Anyway, the over-
all protonmotive Q-cycle starts with the oxidation of ubiquinol to
ubiquinone at the Qo site, whereupon the two electrons are fed into
a high-potential and low-potential chain in a bifurcated manner
[18,22]. One electron (the ‘ﬁrst electron’ in sequential models, see
Section 2.1.2) is transferred to the binuclear iron–sulfur cluster of
the Rieske protein (Fig. 1). The ﬂexible head of the reduced Rieske
protein then moves from the ‘b-position’ (close to cytochrome b) to
the ‘c1-position’ (close to cytochrome c1) and the electron is trans-
ferred via the heme of cytochrome c1 to soluble cytochrome c. Simul-
taneously, two protons are released on the positive side of the
membrane (intermembrane space in the case of mitochondria).
The other (second) electron enters the low-potential chain at heme
bL (low potential heme b) and is transferred via heme bH (high
potential heme b) onto ubiquinone bound to the Qi site, leading to
the formation of a stabilized semiquinone that can be detected by
EPR spectroscopy [57]. To complete the Q-cycle a second ubiquinol
is oxidized at the Qo site, two more protons are released at the posi-
tive side of the membrane and a second cytochrome c is reduced via
the high potential chain, while a second electron transfer through
the low potential chain eventually reduces the semiquinone to
ubiquinol at the Qi site. This is accompanied by the uptake of two pro-
tons from the negative side of the membrane (matrix in the case of mi-
tochondria). In summary, the net translocation of 2H+/2 e− is achieved
by a directed uptake and release of protons at topologically separated
ubiquinol-oxidation and ubiquinone-reduction sites, located at oppo-
site sides of the membrane, and the vectorial transport of electrons
through cytochrome b towards the negative side of the membrane
(Fig. 1).2.1.2. Mechanism of electron bifurcation during ubiquinol oxidation
Understanding the exact molecular mechanism of ubiquinol oxida-
tion at the Qo site is indispensable as it is the most critical step in the
protonmotive Q-cycle for a number of reasons. First of all, it is the
energy conserving reaction and is the prerequisite to vectorial proton
translocation. Second, it is generally accepted that (unwanted) short
circuits at this site would result in unproductive or even deleterious
aberrant electron transfer including the formation of superoxide (for a
review see [22]). Such short circuits or bypass reactions are largely
suppressed in the native (not inhibited) complex III and the production
of superoxide is low. To understand the molecular mechanism of
ubiquinol oxidation it would be beneﬁcial to know the exact position
of the substrate at the Qo site, but none of the crystal structures have
revealed it yet [41,42]. Nevertheless, cytochrome bc1 complexes from
different sources [32–36,58] have been crystallized with competitively
acting Qo site inhibitors giving a hint where substrate molecules may
bind. The structural and kinetic data [58] indicate that binding of
these inhibitors is mutually exclusive, suggesting overlapping dis-
tal and proximal binding sites towards heme bL. Accordingly a
double-occupancy Qo site model has been proposed by Dutton
and coworkers for the R. capsulatus cytochrome bc1 complex in
which two ubiquinones cooperate at the primary steps of the cata-
lytic reaction [59–62]. In addition, binding of two ubiquinones at
the Qo site has been shown for the bovine cytochrome bc1 complex
with a NMR-based method [63]. On the other hand a number of
single occupancy models have been proposed which include simul-
taneous, as well as sequential electron transfer to the primary
acceptors, i.e. the Rieske iron–sulfur protein and heme bL (Fig. 2)
[18,19,21,22,64–66]. Despite fundamental differences (Fig. 2) all
models include a mechanistic constraint or gating that suppresses
potential short circuits or bypass reactions. Brandt [64] explained
the obligate bifurcation of electron ﬂow at the Qo site (center P)
by combination of a ‘catalytic switch’ of the Rieske iron–sulfur pro-
tein between two positions and a chemical control of ubiquinol
oxidation that forbids the simultaneous occurrence of a (negatively
charged) semiquinone species and a reduced heme bL at the Qo site.
Highlighting the complete reversibility of the Q-cycle, Osyczka et al.
[22,52] suggested a ‘double-gating’ mechanism incorporating a semi-
quinone as intermediate that allows ubiquinol oxidation when the
Rieske FeS-cluster and heme bL are both oxidized, aswell as ubiquinone
reduction in the reverse mode, when FeS-cluster and heme bL are both
reduced, but forbids quinone electron transfer when the FeS-cluster is
oxidized and heme bL is reduced. A semiquinone as a true intermediate
in a sequential mechanism of ubiquinol oxidation has been also includ-
ed in othermodels [21]. Even suchmodels imply that ubisemiquinone is
formed only transiently at the Qo site, and never accumulates to signif-
icant amounts in the functional enzyme. Hence the occupancy of this
redox intermediate is expected to be extremely low and formation of
a Qo site-associated semiquinone has been proven very difﬁcult to
show experimentally — even under conditions that should promote
its occurrence, i.e. in the presence of the Qi site inhibitor antimycin A
or in a heme bH knockout mutant [67–69]. In contrast, Yu and
co-workers could not detect a semiquinone in R. sphaeroides mutants
lacking heme bH or heme bL [70]. Inmodels proposing a concerted elec-
tron transfer from ubiquinol onto both redox centers, the participa-
tion of a semiquinone intermediate is completely excluded
[22,52,65,66] (Fig. 2). Such a scenario is supported by investiga-
tions of pre-steady state reduction kinetics of the bc1 complex
redox prosthetic groups (cytochromes and the Rieske protein)
[66,71]. The fundamental question, whether a semiquinone is a
true intermediate during ubiquinol oxidation, has immediate
implications for the mechanism of superoxide formation at the Qo
site (Fig. 2). Very recently, it was proposed that molecular oxygen
acts as a mediator for the electron transfer from QH2 to heme bL
during the bifurcated oxidation of ubiquinol [72]. However, this
suggestion disregards the fact that the catalytic mechanism of
Fig. 1. The protonmotive Q-cycle of the cytochrome bc1 complex. Schematic model illustrating the approximate positions of the redox cofactors and the ubiquinone binding sites of
the functional dimer. Electron transfer within one monomer is indicated by solid black arrows, protonation/deprotonation by solid gray arrows. The oxidized form of ubiquinones in
a partial redox reaction is shown in green and the reduced form is shown in blue. A white arrow indicates the movement of the ﬂexible head of the Rieske protein from the
b-position (colored symbol) to the c1-position (gray). Bifurcated ubiquinol oxidation at the Qo site directs one electron to the high-potential chain (FeS, Cyt c1), and the other to
the low-potential chain (Cyt bL, Cyt bH). In the ﬁrst half cycle, one cytochrome c (Cyt c) is reduced at the positive side of the membrane in addition to the reduction of ubiquinone
to ubisemiquinone at the Qi site. During the second half cycle, a second Cyt c is reduced in addition to the reduction of the ubisemiquinone to ubiquinol at the Qi site. The complete
cycle translocates 2 charges/2 electrons across the inner membrane. For further details see text.
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been evolved in ancestral enzymes in a low oxygen environment
[54].
2.2. Molecular mechanism of superoxide production at the ubiquinol
oxidation site
2.2.1. Superoxide is produced at the ubiquinol oxidation site (Qo site,
center P)
That superoxide is indeed produced at the Qo site and not at the Qi
site has been shown by the use of speciﬁc inhibitors that bind to the
two distinct ubiquinone binding sites. A vast number of studies (e.g.
[25–29,73–78]) that used differentially complex preparations (intact
mitochondria, submitochondrial particles, puriﬁed cytochrome bc1
complexes) from diverse sources (photosynthetic bacteria, mitochon-
dria from yeast and mammals — mainly from heart) have shown that
the superoxide production at complex III is enhanced upon addition
of the Qi site inhibitor antimycin A. The rate is strongly increased
under conditions of so-called oxidant-induced reduction, i.e. if the
presence of sufﬁcient amounts of reducing equivalents leads to
the reduction of the b-type hemes and the downstream respiratory
chain (cytochromes c1 and c) is oxidized at the same time [79].
Importantly, the antimycin A induced superoxide production is
blocked by the addition of Qo site inhibitors [26–28,76,77]. It
emerged that the ‘distal’ Qo site inhibitor stigmatellin completely
abolishes the superoxide production while binding of a ‘proximal’
Qo site inhibitor like myxothiazol caused only a partial reduction
and can even per se induce superoxide production at a lower rate
[26,27,80]. This might be explained by the fact that both types of
inhibitors bind to different niches of the Qo site which have inde-
pendent functions [27] as implicated by the double-occupancy Qo
site model proposed by Dutton and coworkers. It may be also at-
tributed to the fact that stigmatellin is a much more ‘tight’ Qo site
inhibitor than myxothiazol, because it raises the midpoint poten-
tial of the Rieske protein by 250 mV [81] and arrests its ﬂexible
head domain in the ‘b-position’ [82]. It was shown that binding of
stigmatellin to only one monomer per dimer is sufﬁcient to abolishcatalytic activity of the cytochrome bc1 complex [81,83,84]. How-
ever, it was observed that stigmatellin binding to the fully oxidized
cytochrome bc1 complex from R. sphaeroides induces reduction of
the Rieske FeS-protein and superoxide production even in the ab-
sence of the substrate ubiquinol [84]. The authors concluded that
the Rieske FeS-protein becomes a strong oxidant upon stigmatellin
binding and extracts electrons from an organic compound, likely an
amino acid residue leading to the formation of organic radicals that
can be detected by EPR. The strong increase of the midpoint poten-
tial of the Rieske FeS-protein implies that such a reaction is not re-
versible, i.e. that the Rieske FeS protein stays reduced, indicating
that stigmatellin binding would not lead to a continuous produc-
tion of radicals.
The maximal rates of antimycin A-induced superoxide generation
by puriﬁed cytochrome bc1 complexes from yeast and bovine heart
are around one molecule superoxide per second and cytochrome bc1
complex [26–28,85]. Sun and Trumpower [86] found about 10-times
higher rates, but these results might be misleading because the applied
method (cytochrome c reduction±SOD) even gave high rates for the
uninhibited complexes from yeast and bovine heart. In any case, studies
with the puriﬁed enzymes have to be interpreted with caution since
electrons have to be supplied by artiﬁcial hydrophilic ubiquinols that
can per se cause substantial background rates, especially in the presence
of detergents and cytochrome c [28]. Direct ubiquinol oxidation by cyto-
chrome c, accompanied by the production of superoxide, has been ob-
served in protein-free phospholipid vesicles [87]. This implies that any
reduction of the catalytic activity – either by inhibition, mutation or
by a preparation-dependent impaired structural integrity – may pro-
mote non-catalytic superoxide production in a system that uses extrin-
sic cytochrome c and short-chain (comparably hydrophilic) ubiquinol
derivatives, because substrate concentrations will be kept high. Fur-
thermore, the supplied substrates (ubiquinols and cytochrome c)
can give background rates with dyes that are commonly used for
ROS detection. For instance ubiquinols may react with components
of the Amplex Red/HRP assay [28] while cytochrome c can directly
oxidize dichlorodihydroﬂuorescein (H2DCF) [88,89]. It has also to
be mentioned that in contrast to complex I, a downstream block at
Fig. 2. Different mechanisms describe the bifurcation of electrons during ubiquinol oxidation and the generation of superoxide at the Qo site. Reduced cofactors are shown in black,
oxidized cofactors and the semiquinone (SQ) that is generated by the catalytic forward reactions are shown in red, while the very transiently occurring semiquinone that is formed
by reverse electron transfer from reduced heme bL is shown in blue. Electron transfer is indicated by solid black arrows, white arrows indicate the movement of the ﬂexible head of
the Rieske protein. Side reactions that lead to the formation of superoxide are indicated by blue arrows. In the concerted mechanism, both electrons are transferred at the same time
onto the FeS protein and the heme bL, respectively. A semiquinone intermediate does not occur in the catalytic forward reaction and – as a consequence – superoxide production is
only possible by the semireverse reaction. Oxidized Q that is very transiently reduced to semiquinone serves as a redox mediator for the reverse electron transfer from heme bL to
molecular oxygen. In the sequential mechanism of ubiquinol oxidation, the ﬁrst electron is transferred onto the FeS protein which leaves a semiquinone intermediate at the Qo site
and then the second electron is transferred to heme bL. Superoxide production could occur (i) by a semiforward mechanism from the semiquinone intermediate or (ii) by a
semireverse mechanism after the second electron has been transferred to heme bL. For further details see text.
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generation from the Qo site [77]. This can be explained by the fact
that a tight inhibition of complex IV would result in an almost
complete reduction of cytochrome c and the Q-pool suppressing
superoxide generation by either a semiforward mechanism or a
semireverse mechanism (see Section 2.2.3). In accordance, a reduc-
tion of the antimycin A-induced superoxide production by cyanide
has been observed [90].
2.2.2. The membrane potential and the redox state of the Q-pool have
major impact on superoxide production
Since superoxide production of native cytochrome bc1 complexes
is only substantial during inhibition by Qi site inhibitors like
antimycin A [75,91], one has to critically ask which factors could in-
crease ROS generation at the Qo site under physiological conditions.
Rottenberg and colleagues [92] could show in experiments with puri-
ﬁed reconstituted yeast cytochrome bc1 complex that the superoxide
formation strongly depends on the applied membrane potential and
can reach values similar to those promoted by antimycin A. The rate
of superoxide generation increased exponentially with the mem-
brane potential (Fig. 3). This suggests that the membrane potential
severely slows down electron transfer from heme bL to heme bH
thereby promoting a more reduced state of heme bL which then
increases superoxide generation. This can be predicted since the
electron transfer from heme bL to heme bH is the only transmembrane
electrogenic step in the Q-cycle. Furthermore, the investigation
clearly showed that the membrane potential alone and not the
protonmotive force determines the rate of superoxide production[92]. A strong effect of the membrane potential on complex III
superoxide production has already been suggested by an early study
using succinate-fueled isolated mitochondria [93]. Yet ROS genera-
tion under the chosen conditions can be largely attributed to complex
I due to reverse electron transfer from complex II [94–96] and pre-
sumably also to speciﬁc dehydrogenases of the TCA cycle due to an
increased NADH/NAD+ ratio [97].
The redox state of the Q pool is another factor with major impact
on the superoxide production at the Qo site (Fig. 3) —at least for the
antimycin A-inhibited complex III [28]. By analyzing ROS production
of submitochondrial particles (SMPs) from bovine heart with succi-
nate as the sole electron source, we observed an increase of the
antimycin A-induced superoxide production rate when the electron
supply was reduced by addition of the competitive complex II inhib-
itors malonate or oxaloacetate [28] or inhibitors that bind to the
ubiquinone binding site of complex II [31,98]. ROS generation was
maximally increased by a factor of ~3 when approximately 75–85%
of the succinate oxidase activity was inhibited, whereas with further
inhibition superoxide generation decreased again. Such a stimulating
effect of complex II inhibitors on the antimycin A-induced ROS gener-
ation by complex III has also been observed by others [75,76,99–102]
and an impact of the Q-pool redox state has been proposed. Similarly,
titrating the redox status of the Q-pool by varying succinate:fumarate
ratios resulted in a bell-shaped curve for antimycin A-dependent
superoxide generation of alamethicin-permeabilized rat heart mito-
chondria [80]. In intact mitochondria antimycin A-induced ROS
generation is also maximal at intermediate redox states of the Q-pool
that can either be titrated by inhibiting complex II in succinate-fueled
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or II [78]. By far the highest rates of antimycin A-induced ROS pro-
duction of intact mitochondria were observed in the presence of ‘opti-
mal’ complex II inhibitor concentrations and an uncoupler [31,98],
whereas an uncoupler alone increased the rate to a lesser extent
[31,75,90,94]. Uncoupling probably impedes the antioxidative
defense of mitochondria which at least partly depends on the
ΔpH-dependent transhydrogenase for regeneration of reducing
equivalents [103] and hence increases the detectable ROS ‘release’,
but not the actual production. Alternatively/additionally it was
shown that even in the presence of antimycin A and the complex
II inhibitor malonate, an uncoupler further oxidized the Q-pool,
while the b hemes remained reduced [75].
To test whether partial oxidation of the Q-pool indeed stimulates
the antimycin A-induced superoxide production by cytochrome bc1
complex, we directly titrated the ubiquinone to ubiquinol ratio by
mixing oxidized and reduced forms of decylubiquinone [28]. In
submitochondrial particles and in the puriﬁed, lipid-activated com-
plex III from bovine heart mitochondria the rate increased propor-
tionally with increasing ratios of the oxidized form until 25–30%
was reached. We concluded that the generation of superoxide at the
Qo site occurs by reverse electron transfer from reduced heme bL
onto molecular oxygen. While our model also includes a semiquinone
as a short-lived electron donor for superoxide production, this
semiquinone is not the intermediate formed during normal catalytic
forward reaction thought to ‘accumulate’ during antimycin A inhibi-
tion as the source for superoxide [25,26,69,78,104,105] (Fig. 2). Rath-
er ubiquinone serves as a ‘redox mediator’ that transfers electrons
from reduced heme bL onto molecular oxygen. In a detailed analysis
with rat skeletal muscle mitochondria Quinlan and colleagues [78]
not only conﬁrmed that the maximal antimycin A-induced superoxide
generation rate occurs at an intermediate redox state of the Q-pool,
but they could further correlate this with the redox state of heme bL,
showing that Qo site ROS production peaks at about 70–80% heme bL re-
duction. An additional applied membrane potential entailed a reduced
maximal rate of superoxide generation, which occurred at complete re-
duction of heme bL and was also inﬂuenced by the redox state of heme
bH [78]. In conclusion this thorough study suggests that the Q-pool
redox state and the membrane potential modulate superoxide produc-
tion at the Qo site by affecting the reduction states of cytochromes bL
and bH.Fig. 3. Factors and respiratory chain complexes with an impact on the superoxide generation
the Q-pool is at intermediate levels (at least under conditions of oxidant-induced reductio
redox state of the Q-pool is mainly determined by the activities of upstream respiratory ch
mined by the concerted activity of complexes I, II, III, IV and V (and presumably other protei
c pool will attenuate the superoxide production at the Qo site (see text), while oxidized cy2.2.3. Mechanistic considerations: a semiforward or semireverse
mechanism?
There is still an ongoing debate whether superoxide is generated
at the Qo site via an ‘accumulation’ or stabilization of a semiquinone
that also occurs during normal catalytic turnover – representing the
‘classical view’ [25,26,69,78,104,105] (Fig. 2) – or by a direct [106]
or indirect (via oxidized ubiquinone) ‘reverse’ electron transfer from
reduced heme bL onto molecular oxygen [28,30]. Using the words of
Osyczka and colleagues, the question is whether superoxide is formed
by a semiforward or a semireverse mechanism [29,30]. This has also
important implications for the mechanism of ubiquinol oxidation at
the Qo site and vice versa, since a concerted reaction excludes super-
oxide generation by a semiforward mechanism. Osyczka and
colleagues [29,30] who carefully analyzed the superoxide production
of different cytochrome bc1 mutants of R. capsulatus came to the
conclusion that the superoxide production is dominated by a
semireverse mechanism whereas the contribution of the semiforward
mechanism is likely to be minor since only the semireverse model
matched the experimental data for the antimycin A-inhibited wild
type enzyme and all analyzed mutants with a remarkable degree
[30]. In contrast, a kinetic model of Quinlan and coworkers based on
their analysis of antimycin A-induced superoxide production,
implemented a semiquinone generated in the semiforward reaction
as an indispensable component [78]. Like in other mathematical
models describing superoxide generation by the cytochrome bc1 com-
plex [107–109], the outcome is clearly inﬂuenced by the favored funda-
mental mechanism that may not consider some proposed mechanistic
restrictions, e.g. that a reduced heme bL and a semiquinone cannot coex-
ist at the Qo site [2]. The superoxide generation at the Qo site is intrinsi-
cally tied to the mechanism of electron bifurcation during ubiquinol
oxidation. While a semireverse reaction of superoxide generation
workswith a concerted and a sequentialmechanismof ubiquinol oxida-
tion, a concerted mechanism does not allow a semiforward reaction of
superoxide generation. Hence, the semireverse mechanism appears
more likely.
2.3. Residues/subunits of complex III that affect superoxide production
Several studies with cytochrome bc1 complexes from S. cerevisiae
and Rhodobacter species indicate that mutations which severely im-
pede the electron ﬂow through the low potential or the high potentialby complex III. The rate of superoxide production is increased when the redox state of
n, e.g. in the presence of antimycin A) and when the membrane potential is high. The
ain complexes (especially complexes I and II) while the membrane potential is deter-
ns like the uncoupling proteins that are not shown). A completely reduced cytochrome
tochrome c is an effective superoxide scavenger thereby reducing the release of ROS.
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cluster of the Rieske protein) result in superoxide production at the
Qo site. In contrast to most of the work described above (see Section
2.2.1) an increased superoxide production was also observed in the
absence of antimycin A. In most instances these mutants have a dras-
tically reduced catalytic turnover, but this seems not to be a general
prerequisite for increased superoxide generation [30]. Mutations in
the Qo site of yeast [110,111] and bacterial (R. capsulatus) [112]
enzymes including a conserved tyrosine residue (Tyr279 of yeast,
Tyr302 of R. capsulatus cytochrome b) that affect binding and oxida-
tion of ubiquinol showed transfer of an increased fraction of electrons
from ubiquinol onto molecular oxygen with regard to the catalytic
electron transfer to cytochrome c. Interestingly, a mutation of the
homologue tyrosine (Tyr278 of cytochrome b) in human cytochrome
bc1 complex causes ‘multisystem disorder’ (deafness, mental retarda-
tion, growth retardation, etc.) [113]. Yet some of the mutants featured
a low turnover number, meaning that observed increases of the
relative rates do not necessarily reﬂect an increase of absolute super-
oxide production compared with the wild type enzymes. Yu and
coworkers analyzed the superoxide production of R. sphaeroides cyto-
chrome bc1 complexes lacking the cofactors heme bL or heme bH, re-
spectively [70]. The puriﬁed complexes of both mutants produced as
much superoxide as the antimycin A-inhibited wild type complex.
Inhibition by antimycin A had little effect on the superoxide produc-
tion of the mutant complexes, indicating that it is indeed produced
at the Qo and not at the Qi site. The ﬁnding that the complex lacking
heme bL produces superoxide supports a semiforward rather than a
semireverse mechanism. On the other hand, a semiquinone radical
could not be detected by EPR measurements and the authors
suggested that molecular oxygen may share quinol electrons with
the Rieske protein when heme bL is not available [70]. Bacterial
mutant complexes lacking the Rieske protein [84] or containing a ste-
rically arrested FeS domain close to the Qo site (‘FeS motion knock-
out’) [29,30] do not produce signiﬁcant amounts of superoxide,
even in the presence of antimycin A [29]. Osyczka and coworkers con-
cluded from their studies with different ‘FeS motion knockouts’ that
the generation of superoxide only occurs when the FeS head domain
transiently leaves the Qo site (moves to the c1 position) during the
catalytic cycle, while when arrested at the b position the FeS head
effectively diminishes the probability of superoxide formation
[29,30]. Mutations of cytochrome c1 (Met183 in R. capsulatus) causing
severely impeded electron ﬂow through the high potential chain by
dramatically slowing the oxidation of the FeS center lead to increased
electron transfer onto molecular oxygen given that the ubiquinol con-
centration is high or the cytochrome c1/cytochrome c interaction is
attenuated by high ionic strength [29,30].
3. Factors inﬂuencing the release of superoxide generated by complex
III
3.1. Complex III releases ROS into different mitochondrial compartments
At physiological pH, superoxide exists mainly in its anionic charged
form [114] that is highly membrane-impermeable [115,116]. Thus,
mitochondrial superoxide production is characterized by a distinct
membrane sideness or topology of release, respectively [117], which
might have important implications for the onset of pathophysiological
processes or cellular redox signaling. However, the dismutation product
hydrogen peroxide (H2O2) can readily cross membranes. The funda-
mental studies of St. Pierre et al. [91] andMuller et al. [117] with isolat-
ed mitochondria revealed that the cytochrome bc1 complex releases
superoxide at least partially into the intermembrane space (and the
cytoplasm), while complex I releases superoxide exclusively into the
matrix. These ﬁndings are in agreement with the available structures
of the twomitochondrial complexes: the Qo site of complex III is imme-
diately adjacent to the intermembrane space [41,42] whereas theproposed site(s) of superoxide generation of complex I [2], the FMN
[118,119] and possibly also the ubiquinone binding site [120] are both
located in the peripheral arm that protrudes into thematrix [121].Mull-
er et al. [117] concluded from their studies that ~50% of the superoxide
produced at the Qo site is released into the intermembrane space and
that the remaining ~50% have to be released into thematrix. Drawbacks
of this and other studies are that (i) the portion of superoxide released
into the twomainmitochondrial compartments (intermembrane space
andmatrix)was determined indirectly as an effect of added SOD and/or
(acetylated) cytochrome c which cannot enter the intermembrane
space and cristae lumen of intactmitochondria and (ii) the spontaneous
rate of superoxide dismutation (105 M−1 s−1 [122])was not taken into
account. Considering the mitochondrial ultrastructure with cristae
deeply folded into the matrix [123] we think that the superoxide
production was underestimated and propose that superoxide is exclu-
sively released into the intermembrane space as suggested by St. Pierre
et al. [91]. However, after (spontaneous or SOD-catalyzed) superoxide
dismutation, a signiﬁcant fraction of the emerging H2O2 diffuses from
the cristae lumen to the matrix and potentially oxidizes protein thiols
(Fig. 4; Bleier et al., unpublished results). Cadenas and colleagues
noted that the intermembrane space appears to possess a less efﬁcient
peroxidase activity than themitochondrialmatrix [124] and that super-
oxide (and derivedH2O2) generated at the intermembrane space side of
the inner membrane might be more effectively released into the
cytoplasm via porins than ROS released to the matrix [124,125]. These
considerationsmight be relevant for the role of ROS as ‘secondmessen-
gers’ during cellular redox signaling.
3.2. Cytochrome c and antioxidative systems
One factor that can attenuate the release of superoxide from the
Qo site is cytochrome c that is present in high concentration in the
intermembrane space [126]. Oxidized cytochrome c [127,128] and
cytochrome c oxidase form an efﬁcient scavenging system for super-
oxide [126]. Besides, some SOD1 is present in the intermembrane
space [129] that accelerates the dismutation of superoxide and
increases the rate of H2O2 generation (Fig. 4). After dismutation
H2O2 can diffuse to the cytoplasm or into the matrix, where it is
very efﬁciently removed by the mitochondrial antioxidative system
[130–133] encompassing the glutathione/glutathione peroxidase
and thioredoxin/peroxiredoxin systems which were shown to affect
the release of Qo site derived ROS [134].
3.3. Complex III activity inﬂuencing ROS generation at other mitochondrial
sites
It has to be noted that inhibition of complex III activity – either by
inhibitors of the Qo site (e.g. myxothiazol or stigmatellin) or the Qi
site (antimycin A) or by mutations that reduce complex III activity –
will induce superoxide production at complex I if NADH is present
[28,31,77,135]. From studies with bovine heart SMPs it can be
deduced that in the presence of NADH and antimycin A superoxide
is generated in equal parts at complex I and the Qo site of complex
III since the rate is reduced to 50% by the addition of stigmatellin
[28]. Furthermore, the complex I inhibitor DQA and stigmatellin
both induced a similar rate of ROS production. Very recently, Quinlan
and colleagues could show that complex II also produces superoxide
in the presence of low succinate concentrations if complex III is
blocked by myxothiazol [136].
4. Are complex III derived ROS involved in cellular redox signaling?
Meanwhile mitochondrial ROS are not only considered as damag-
ing by-products from respiration, but also as redox signaling mole-
cules in various physiological and pathophysiological processes
[9–11]. While numerous studies indeed report mitochondrial ROS as
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considerably less studies deal with the actual ROS generating source.
Nevertheless, a regulatory role of complex III-generated ROS in the cel-
lular adaptive response to hypoxia, aswell as in related cardioprotective
ischemic preconditioning has been suggested by numerous studies (see
Table 1).
In particular a crucial role for complex III-derived ROS in stabiliza-
tion of the hypoxia-inducible factor HIF-1α in response to hypoxia
has been proposed (for reviews see [15,137,138]). HIF-1α is stabi-
lized by impeded hydroxylation of prolyl-residues which suppresses
proteasomal degradation and hence enables nuclear translocation of
the HIF-heterodimer to induce transcription of various gene products
involved in angiogenesis, metabolism and erythropoiesis (for review
see [139]). Initial evidence of a functional involvement of mitochon-
dria came from Schumacker's group showing that mtDNA depleted
ρ0 cells failed to activate hypoxia-induced transcription [140]. Subse-
quently, the requirement of mitochondrial ROS, more precisely
hydrogen peroxide as signaling molecule for HIF-1α stabilization
and mitochondrial complex III as the superoxide-generating site
was demonstrated. Much of the information was gained by cell
culture preparations and the use of speciﬁc mitochondrial ETC inhib-
itors, other inhibitors and enzymatic or chemical antioxidants or
oxidants [12,13,141–144]. Genetic data obtained from knockdown
of complex III subunits, like the Rieske [13,142] and cytochrome b
[144] or downstream components of the electron transfer chain like
cytochrome c [143], as well as from overexpression of components
of the antioxidative system [12,13,142], conﬁrmed an involvement
of complex III ROS and disproved earlier controversial reports
[145,146]. Yet, some conclusions drawn from a study [144] using
cybrid cells deﬁcient of cytochrome b [147] barely withstand from a
bioenergetic point of view, as it was proposed that those cells still
generate Qo-site ROS though the Qo site is located within the cyto-
chrome b [41,42]. A general problem in studying the actual underlying
ROS generator site appears to be the necessity to apply speciﬁc inhibitors
or to knockdownsubunits of the complex. Complex III inhibition in partic-
ular, as electrons cannot bypass downstream, inevitably affects other
ROS-modulating factors like the membrane potential, ratios of ADP/ATP
and NAD(P)+/NAD(P)H or induces a shift in metabolism. Nonetheless,
any contribution to HIF-1α stabilization from complex I, the other main
mitochondrial ROS source seems unlikely since a fully reduced down-
stream electron chain evoked by complex III inhibition should promote
complex I ROS generation, though hypoxic signaling was found dimin-
ished under these conditions in all studies. Yet the role of Qo site ROS gen-
eration in response to hypoxia is still controversially discussed as studies
using isolated mitochondria observed decreased mitochondrial ROS gen-
eration with decreasing oxygen partial pressure [148]. Direct oxygenFig. 4. Topology of ROS release from the Qo site and implications for redox signaling. In our
into the intermembrane space and the cristae lumen that encompass the main portion of the
either react with oxidized cytochrome c or be readily dismutated to hydrogen peroxide. H2O
consumed by the antioxidative system (especially by the thioredoxin (Trx)/peroxiredoxin (
unpublished results show an oxidation of thiols groups of proteins located in the intermembrsensing by mitochondrial complex III, as suggested before, is challenged
by thisﬁnding and adifferent triggeringmechanismmust be assumed. In-
terestingly, a study showed that terpestacin, a small molecule targeting
complex III subunit UQCRB, abrogated hypoxia-induced ROS generation
without affecting respiration [149]. This shows that in principle an acces-
sory subunit can regulate superoxide generation by complex III. Recently,
Bell and coworkers suggested that acetylation of complex III subunits
might alter its ROSproduction, as they could show that knockdownofmi-
tochondrial deacetylating sirtuin SirT3 augmented ROS levels and HIF-1α
stabilization in response to hypoxia [150].
Apart from HIF-1α stabilization mitochondrial complex III-generated
ROS have been implicated in hypoxia-induced calcium increase and
subsequent pulmonary vasoconstriction (for reviews see [151–153]).
Hypoxic pulmonary vasoconstriction (HPV) as an important physiolog-
ical response to hypoxia ensures sufﬁcient oxygenation of the blood by
optimizing thematching of alveolar ventilation to pulmonary perfusion
(for review see [154]). Likewise to their role in HIF-1α stabilization,
evidence for the involvement of Qo-site-generated ROS in HPV was
mostly gained by use of speciﬁc pharmacological inhibitors, antioxi-
dants or oxidants, as well as by genetic manipulation [155–160]. Yet,
elevated ROS levels for hypoxic adaptation in pulmonary artery smooth
muscle cells are controversially discussed as other groups favor a
decrease in ROS levels as signaling mechanism for HPV [161–166].
Further, complex III-generated ROS seem to act as second messen-
gers in the context of cardioprotective ischemic and pharmacological
preconditioning (for reviews see [6,167]). Cardioprotective ischemic
preconditioning refers to short, intermittent ischemic periods prior to
prolonged cardiac ischemia thereby diminishing downstream cardiac
damage by ischemia reperfusion injury. This phenomenon can be
mimicked by pharmacological drugs such as diazoxide. Early studies
observed that antioxidants prevented cardioprotection by precon-
ditioning suggesting a signaling role for ROS [168–172]. Subsequent
support came from studies showing a modulatory effect of diazoxide
on mitochondrial ROS generation [31,101,173]. Two early studies
indicated an involvement of Qo site-generated ROS demonstrating
that the Qo site inhibitor myxothiazol diminished ROS production and
cardioprotection [168,174]. Yet the underlying triggering mechanisms
are not fully understood. Based on observations that diazoxide also
inhibits mitochondrial complex II [175–177], as well as other complex
II inhibitors exert cardioprotective effects [178,179] a link between
modulation of Qo site ROS generation by complex II activity and
cardioprotection seems plausible. It is amatter of debatewhether open-
ing of a putative mitoKATP channel is also involved in evoking Qo site
ROS generation [179,180]. Recently, we showed that partial inhibition of
complex II augments complex III Qo site ROS generation via a more
oxidized Q-pool [28], and in a potassium independent mannermodel, the primarily formed superoxide is almost completely released from the Qo site
inner membrane in intact mitochondria. The membrane-impermeable superoxide can
2 can diffuse across membranes thereby reaching the matrix where the bulk is probably
Prx) system and glutathione (GSH)/glutathione peroxidases (Gpx)). Nevertheless, our
ane space and the matrix by complex III derived ROS (Bleier et al., unpublished results).
Table 1
Selected studies on complex III-derived ROS in cellular signaling.
Biological process Cell culture (and other) preparationsa Evidence obtained by use of ROS detectionb Ref
Response to hypoxia
HIF-1α stabilization Hep3B; Hep3B ρ0 ETC inhibitors; antioxidants DCF(H)-DA [140]
Hep3B; Hep3B ρ0; 293; 293 ρ0 ETC inhibitors, antioxidants, oxidants,
genetic approaches (catalase overexpression)
DCF(H)-DA [12]
A549; A549 ρ0; HT1080; HT1080 ρ0;
293; CCL16-B2; CCL16-NDI1
ETC inhibitors CM-H2DCF-DA [141]
A549; 293; SURF-1 null and WTc; C2C12;
CCL16-B2; CCL16-NDI1
ETC inhibitors, genetic approaches
(Rieske knockdown; SOD1, SOD2, GPx1
and catalase overexpression)
N/A [142]
Hep3B; Hep3B ρ0; 293; 293 ρ0;
143B; 143B ρ0; murine embryonic cells;
cyt c null murine embryonic cells
ETC inhibitors, antioxidants, oxidants,
genetic approaches (generation of
cytochrome c null embryonic cells)
DCF(H)-DA;
carboxy-H2DCF-DA
[143]
Hep3B; 293; 143B; 143B ρ0; murine
embryonic cells, chick embryonic
cardiomyocytes
ETC inhibitors, antioxidants, oxidants,
genetic approaches (Rieske knockdown;
SOD1, SOD2, cytos. and mito-targ.
catalase overexpression)
ROS-sensitive
HSP-FRET probe
[13]
A549; 143B; 143B ΔCyt b cybrids ETC inhibitors, antioxidants, oxidants,
genetic approaches (Rieske knockdown)
Amplex Red;
CM-H2DCF-DA
[144]
Non-hypoxic HIF-1α
stabilization
(Angiotensin II-induced)
Rat vascular smooth muscle cells ETC inhibitors, genetic approaches
(Rieske and HIF-1α knockdown)
MitoSOX [185]
Hypoxic pulmonary
vasoconstriction (HPV)
Rat small intrapulmonary arteries (IPAs) ETC inhibitors N/A [155]
Rat pulmonary artery myocytes, pulmonary
artery myocytes ρ0, perfused rat lungs
ETC inhibitors, antioxidants DCF(H)-DA [156]
Rat pulmonary artery myocytes ETC inhibitors, oxidants, genetic
approaches (catalase overexpression)
Xylenol orange assay [157]
Rat PASMCs ETC inhibitors, antioxidants, oxidants,
genetic approaches (SOD1, SOD2, cytos.
and mito-targ. catalase, GPx1 overexpression)
ROS-sensitive
HSP-FRET probe
[158]
Mouse PASMCs; isolated, perfused
and ventilated rabbit lungs
ETC inhibitors, simultaneous plotting
of respiration and mitochondrial
cytochromes redox state
MitoSOX [159]
Rat PASMCs; rat SASMCs Antioxidants, oxidants, genetic
approaches (cytos. and mito-targ.
catalase overexpression)
RoGFP [160]
Cardioprotective
preconditioning
Embryonic ventricular cardiac myocytes ETC inhibitors, antioxidants, oxidants DHE; DCF(H)-DA [168]
Adult rabbit ventricular myocytes ETC inhibitors and antioxidants MitoTracker™ Red [174]
Adipocyte differentiation Human mesenchymal stem cells (MSCs) Antioxidants, oxidants, genetic approaches
(Rieske, UQCRB and Raptor knockdown;
PPARγ overexpression)
Amplex Red [181]
Apoptosis induction
by matter air pollution
Mammalian cell culture (A549; A549 ρ0;
rat alveolar type II epithelial cells); C57BL/6 mice
Antioxidants, oxidants, genetic approaches
(Rieske knockdown; SOD1 and SOD2
overexpression)
Mito-Ro-GFP [182]
a Hep3B, human Hep3B hepatoma cells; 293, kidney HEK 293 cells; A549, human A549 lung epithelial cells; HT1080, HT1080 human ﬁbrosarcoma cells; 143B, 143B osteosarcoma
cells; murine embryonic cells; PASMCs, pulmonary artery smooth muscle cells; SASMCs, systemic artery smooth muscle cells; CCL16-B2, Chinese hamster lung ﬁbroblast lines
CCL16-B2; CCL16-NDI1, Chinese hamster lung ﬁbroblast lines CCL16-NDI1; C2C12, C2C12 mouse myoblasts.
b Carboxy-H2DCF-DA, 5-(and-6)-carboxy-2′,7′-dichlorodihydroﬂuorescin diacetate; CM-H2DCF-DA, 5-(and-6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescin diacetate acetyl
ester; cytos., cytosolic; DCF(H)-DA, 2′,7′-dichloroﬂuorescin diacetate; DHE, dihydroethidium; MitoSOX, MitoSOX Red mitochondrial superoxide indicator; N/A, not available.
c SURF-1 null ﬁbroblasts from a patient with Leigh's syndrome, which is associated with cytochrome c oxidase deﬁciency [186].
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we proposed as a potential triggeringmechanism for cardioprotection di-
rect modulation of mitochondrial ROS generation via altered complex II
activity [98].
A so far unknown signaling function of complex III-derived ROS in
adipocyte differentiation was recently found by Chandel's group
[181]. The authors reported that complex III ROS initiate adipocyte
differentiation by induction of the PPARγ transcriptional machinery
in an mTORC1-dependent manner. Further, a signaling role of com-
plex III-derived ROS in apoptosis induction by matter air pollution
has been suggested by Soberanes et al. [182].
It can be concluded that growing evidence draws a convincing
picture of Qo site ROS as second messengers in cellular signal trans-
duction. Yet the research ﬁeld faces methodical challenges and
various questions remain to be clariﬁed in order to completely under-
stand the relevant events and mechanisms: (i) A major technical
limitation surely is the reliable detection of ROS, as most ROS
detection methods are highly susceptible to side reactions, lack selec-
tivity or suffer from pH sensitivity, autooxidation or uncontrolled
probe distribution or reaction with antioxidants [183]. Besides,while a variety of different ROS detecting assays exist, there are so
far no reliable approaches to pinpoint the actual ROS-generator.
Hence to fully unravel the function of complex III-generated ROS in
cellular signal transduction, ‘biomarkers’ for the different ROS gener-
ator sites allowing differentiation of the variably contributing mito-
chondrial superoxide sources would be helpful. Thus we studied the
redox status of protein thiols in isolated mitochondria subjected to
different ROS generating conditions by Redox DIGE (difference gel
electrophoresis) [184]. We observed that ROS generated at mitochon-
drial complex I or complex III targeted a distinct subset of proteins
and identiﬁed potential candidates for such ‘biomarkers’ (Bleier et
al., unpublished results). (ii) Mostly, the underlying triggering events
of Qo site signaling ROS are not fully understood. The molecular
mechanisms of signal communication to mitochondria and thus
enhanced Qo site ROS generation need to be further investigated.
(iii) Existing ambiguity regarding the exact mechanism of superoxide
generation by complex III further impedes progress. (iv) For most
cases the biological outcome is well documented, but the direct
biological targets of Qo site signaling ROS remain elusive. Yet, consid-
ering the rapidly advancing ﬁeld of redox proteomics numerous
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promote our understanding of redox signaling and will hold major
implications for various physiological and pathophysiological pro-
cesses, e.g. for cardiac damage and tumorigenesis.
5. Conclusions and outlook
In conclusion it can be noted that the exact mechanism of super-
oxide generation at the Qo site still remains a matter of debate. More-
over, signiﬁcant amounts of Qo site-derived superoxide have been
measured so far only under non-native conditions, e.g. in the presence
of the Qi site inhibitor antimycin A. Thus, the fundamental question
that needs to be addressed is which physiological factors or processes
promote Qo site superoxide generation in vivo. This is of particular
importance considering the reported regulatory role of complex III
derived ROS in cellular redox signaling. In this regard possible
post-translational modiﬁcations of complex III subunits, e.g. acetyla-
tion and their inﬂuence on Qo site superoxide production should be
further investigated as it seems plausible that they may serve as phys-
iological mechanisms to control superoxide generation.
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